Researchers from the School of Veterinary Medicine and Perelman School of Medicine have found that YY1 knockout pro-B cells can generate T lineage cells helping B cells produce antibodies.

Among patients with Crohn's disease, a multicenter prospective cohort study found that anti-TNF therapy failed to achieve remission at 3 years in about two-thirds of cases, and that high drug ...

Development of B cells, white blood cells that make antibodies, follows a progression of stages: common lymphoid progenitors, pre-pro-B cells, pro-B ...

What can we do to turn this around ... Leeds Teaching Hospitals NHS Trust & Boehringer Ingelheim established a clinic for people with cardiovascular disease and type 2 diabetes.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Conclusion HHAT is regulated in SSc in a TGFβ-dependent manner and in turn stimulates TGFβ-induced long-range ... Anamar, Bayer Pharma, Boehringer Ingelheim, Celgene, Galapagos, GSK, Inventiva, JB ...

Boehringer Ingelheim has moved one of its top pipeline ... The first patient has already been enrolled into its FIBRONEER phase 3 programme for BI 1015550, which already has a breakthrough ...

Hosted by Boehringer Ingelheim, the ‘CRM Summit’, an expert engagement ... 1 accounting for up to 20 million deaths annually.2,3 The intricate connection between the CRM systems signifies that disease ...

The chronic and progressive inflammatory disease bronchiectasis is characterised by permanent bronchi dilation and by ...

Boehringer Ingelheim partners with the WHO Foundation to financially support WHO’s Fourteenth General Programme of Work (2025 to 2028). Credit: PeopleImages.com – Yuri A/Shutterstock. Boehringer ...

In March 2008, the European Commission granted marketing authorization for dabigatran etexilate (Pradaxa; Boehringer Ingelheim), a direct ... of hospital stays (mean 3–4 days), only a minority ...

Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare ...